Objective: To determine an underlying genetic defect within the differentia
l diagnosis of congenital multicore myopathy. Background: A 13.5-year-old g
irl presented with congenital-onset facial and neck weakness, slowly progre
ssive severe limb girdle and axial myopathy, respiratory weakness, cardiomy
opathy, progressive joint contractures, lumbar lordosis, progressive extern
al ophthalmoplegia with ptosis, and cataracts. Muscle biopsy at; 3 years re
vealed type I fiber predominance and hypotrophy, multicores with a focal de
crease in mitochondria and oxidative enzymes, and internal nuclei. Methods
and Results: Serum carnitine was decreased (total, 18.2 mu mol/L; free, 11.
7 mu mol/L). Urine organic acids intermittently revealed very large amounts
of ethylmalonic and methylsuccinic acids intermittently, with elevated but
yrylglycine, 2-methylbutyrylglycine, and tiglylglycine. Fibroblast acylcarn
itine profiles revealed marked butyrylcarnitine elevation. Electron-transfe
rring flavoprotein-linked reduction enzymatic assay of fibroblasts with but
yryl-coenzyme A (CoA) as substrate, after immunoinactivation of medium-chai
n acyl-CoA dehydrogenase activity, revealed a complete absence of short-cha
in acyl-CoA dehydrogenase (SCAD) activity. No SCAD protein was detectable w
ith Western blot analysis. Conclusions: This patient expands the clinical p
henotype of SCAD deficiency and emphasizes the need for its consideration i
n the differential diagnosis of progressive external ophthalmoplegia and co
ngenital multicore myopathy.